1. 142TiPRANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF EVOFOSFAMIDE (TH-302) IN COMBINATION WITH PEMETREXED IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER. (16th March 2015) Authors: Goldman, J.; Belani, C.; Novello, S.; von Pawel, J.; Csoszi, T.; Orlov, S.; Kroll, S.; Pearce, T. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 1 Page Start: i44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1O IMpower010: ctDNA status in patients (pts) with resected NSCLC who received adjuvant chemotherapy (chemo) followed by atezolizumab (atezo) or best supportive care (BSC). (December 2022) Authors: Felip, E.; Srivastava, M.; Reck, M.; Wakelee, H.; Altorki, N.K.; Vallieres, E.; Liersch, R.; Harada, M.; Tanaka, H.; Hamm, J.T.; McCune, S.; Bennett, E.; Gitlitz, B.J.; McNally, V.A.; Novello, S.; Ballinger, M.; Zou, W.; Nabet, B.; Das Thakur, M.; Zhou, C. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 222P Platinum-based chemotherapy attenuates the CD8 T cell proliferative response to concomitant PD-1 blockade. (December 2022) Authors: Mariniello, A.; Nasti, T.; Chang, D.; Malik, S.; McManus, D.; McGuire, D.; Buchwald, Z.; Novello, S.; Sangiolo, D.; Scagliotti, G.; Ramalingam, S.S.; Ahmed, R. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 3099 Phase 3 trial (NGR015) of best investigator choice (BIC) with or without NGR-hTNF in previously treated malignant pleural mesothelioma (MPM). (September 2015) Authors: Gregorc, V.; Gaafar, R.; Favaretto, A.; Grossi, F.; Jassem, J.; Polychronis, A.; Bidoli, P.; Tiseo, M.; O'Brien, M.; Shah, R.; Taylor, P.; Novello, S.; Muzio, A.; Bearz, A.; Badurak, P.; Greillier, L.; Fontana, F.; Colombi, S.; Lambiase, A.; Bordignon, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S634 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 3102 Tumour growth over time in patients with advanced non-small cell lung cancer treated with nintedanib plus docetaxel or placebo plus docetaxel: Analysis of data from the LUME-Lung 1 study. (September 2015) Authors: Reck, M.; Buchner, H.; Gottfried, M.; Novello, S.; Mellemgaard, A.; Heigener, D.; Gaschler-Markefski, B.; Kaiser, R.; Douillard, J.Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S635 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) – A decision-making analysis amongst European lung cancer experts. (August 2020) Authors: Früh, M.; Panje, C.M.; Reck, M.; Blackhall, F.; Califano, R.; Cappuzzo, F.; Besse, B.; Novello, S.; Garrido, P.; Felip, E.; O'Brien, M.; Paz Ares, L.; de Marinis, F.; Westeel, V.; De Ruysscher, D.; Putora, P.M. Journal: Lung cancer Issue: Volume 146(2020) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical features associated with early drop-out among outpatients with unipolar and bipolar depression. (April 2021) Authors: Fornaro, M.; Novello, S.; Fusco, A.; Anastasia, A.; De Prisco, M.; Mondin, A.M.; Mosca, P.; Iasevoli, F.; de Bartolomeis, A. Journal: Journal of psychiatric research Issue: Volume 136(2021) Page Start: 522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. (April 2020) Authors: Passiglia, F.; Bertolaccini, L.; Del Re, M.; Facchinetti, F.; Ferrara, R.; Franchina, T.; Malapelle, U.; Menis, J.; Passaro, A.; Pilotto, S.; Ramella, S.; Rossi, G.; Trisolini, R.; Novello, S. Journal: Critical reviews in oncology/hematology Issue: Volume 148(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P002 Adjuvant chemotherapy for resected early-stage triple negative breast cancer. (April 2023) Authors: Solinas, C.; Bertaglia, V.; Parati, M.C.; Borgonovo, K.; De Silva, P.; Pretta, A.; Saba, G.; Migliari, M.; Bardanzellu, F.; Murgia, S.; D'Agata, A.P.; Cadoni, A.; Contu, F.; Cadeddu, M.; Sanna, G.; Luciani, A.; Novello, S.; Scartozzi, M.; Emens, L.A.; Petrelli, F. Journal: Breast Issue: Volume 68(2023) Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PO-0779 Current management of limited-stage SCLC and CONVERT trial impact: an EORTC LCG survey. (April 2019) Authors: Levy, A.; Hendriks, L.E.L.; Le Péchoux, C.; Falk, S.; Besse, B.; Novello, S.; Dingemans, A.C.; Hasan, B.; Reck, M.; Berghmans, T.; Faivre-Finn, C. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗